Chargement en cours...
Treatment with or without bevacizumab as a first‐line and maintenance therapy for advanced non‐squamous non‐small cell lung cancer: A retrospective study
BACKGROUND: Pemetrexed and bevacizumab as monotherapies, or in combination, have been approved for maintenance therapy following platinum‐based induction in patients with advanced nonsquamous non‐small cell lung cancer (NSCLC). The differences in the benefits of bevacizumab for treatment during earl...
Enregistré dans:
| Publié dans: | Thorac Cancer |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons Australia, Ltd
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7327679/ https://ncbi.nlm.nih.gov/pubmed/32406994 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13469 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|